Navigation Links
K-V Pharmaceutical Secures Financing Commitments Establishing Path Forward For Specialty Pharmaceutical Business
Date:11/17/2010

ST. LOUIS, Nov. 17, 2010 /PRNewswire/ -- K-V Pharmaceutical Company (NYSE: KVa/KVb) announced today that it has entered into an agreement with US Healthcare I, L.L.C. and US Healthcare II, L.L. C. (together, the "Lenders") affiliates of New York-based Centerbridge Partners, L.P ("Centerbridge") for a senior secured debt financing package of up to $120 million consisting of (1) a fully funded $60 million term loan (the "Bridge Loan") that will retire the previously announced $20 million loan provided by the Lenders and provide for general corporate and working capital purposes and (2) a commitment to provide a multi-draw term loan up to an aggregate principal amount of $120 million consisting of three tranches that will be available to the Company for purposes that include the retiring of the Bridge Loan, following its satisfaction of certain conditions, including the pending approval of Gestiva™ which has an U.S. Food and Drug Administration action date of January 13, 2011.

Under the terms of the Bridge Loan agreement, the Company will pay interest at an annual rate of 16.5% (5% of which shall be payable in kind) with a maturity date of March 2013.  The Company has furnished as collateral substantially all assets of the Company to secure the loan.  The Bridge Loan is guaranteed by certain of the Company's domestic subsidiaries and the guarantors furnished as collateral substantially all of their assets to secure the guarantee obligations.

In addition, the Company issued a stock warrant to the Lenders that grants them rights to purchase up to 9,900,000 shares of the Company's Class A Common Stock, par value $.01 per share (the "Initial Warrant").  Upon the completion of a 10-day notice period to stockholders, the Company will issue a second stock warrant that grants the right to purchase up to 2,687,511 shares of the Company's Class A Common Stock, par value $.01 per share (the "Second Warrant," and together with the Initial Warr
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013  Net Medical Xpress Solutions, Inc., (OTC QB: ... the company has signed a letter of intent to ... Huntsville, AL . MedTel Solutions is ... and recruitment of telemedicine physicians. Consideration for the acquisition ... which is expected by June 30, 2013. ...
(Date:5/23/2013)... Md. , May 23, 2013  BioElectronics Corporation ... consumer medical devices, comments on the FDA panel meeting ... Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting was ... MD , USA.  The focus of the meeting ... the panel to focus solely on the application of ...
(Date:5/23/2013)... Israel Brain Technologies (IBT) has announced ... Israel,s 1 st International Brain Technology Conference, ... in Tel Aviv , recently ranked ... world by the Wall Street Journal and the ... will showcase the latest breakthroughs in neuroscience and brain technology ...
Breaking Medicine Technology:Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3BioElectronics and Pulsed Shortwave Therapy Make Progress 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3
... Masimo (Nasdaq: MASI ) announced today that ... ended October 2, 2010, after the market closes on November 2, ... begin at 1:30 p.m. PT (4:30 p.m. ET) and will be ... P. de Raad, Executive Vice President and Chief Financial Officer. ...
... MacroGenics, Inc. and Eli Lilly and Company (NYSE: ... Monitoring Committee (DMC), composed of independent experts in the ... analysis of one-year safety and efficacy data of the ... biologic under development for the treatment of individuals with ...
Cached Medicine Technology:Masimo to Report Third Quarter 2010 Financial Results After Market Close on November 2, 2010 2Masimo to Report Third Quarter 2010 Financial Results After Market Close on November 2, 2010 3MacroGenics and Lilly Announce Pivotal Clinical Trial of Teplizumab Did Not Meet Primary Efficacy Endpoint 2MacroGenics and Lilly Announce Pivotal Clinical Trial of Teplizumab Did Not Meet Primary Efficacy Endpoint 3
(Date:5/23/2013)... , , WEDNESDAY, May 22 (HealthDay News) -- The success of ... born with a serious airway malformation sheds light on new ... A report in the May 23 New England Journal ... At first, the baby born five weeks early seemed ... eating when he was 6 weeks old. Just two weeks ...
(Date:5/23/2013)... HealthDay Reporter , , WEDNESDAY, May 22 (HealthDay News) ... for detecting lung cancer now have more information to help ... study finds that low-dose CT scans pick up significantly more ... long history of smoking are at high risk for lung ... But doctors have to consider the potential harm of radiation ...
(Date:5/23/2013)... According to a new market report "Service ... Data Management (SDM); Telecom Application Server; Service Creation Environment; ... 2018)", published by MarketsandMarkets, the SDP Market is expected ... of 9.15% from 2013 to 2018. , Browse:, ... 84 Figures , 189 Pages and ...
(Date:5/23/2013)... May 23, 2013 DRE, Inc. is ... as a solution to upgrade older model DRE ... the entire lighting system. , DRE and BFW ... DRE or BFW halogen headlights to LED with DRE’s ... C3 LED Conversion Kit provides a bright, clean and ...
(Date:5/23/2013)... Located at 22343 La Palma Ave. #125, ... its Grand Opening Family Fun Charity event on May 11, ... and physical fitness. Sponsored by many different vendors like Chick-fil-a ... filled Grand Opening featured mini boot camp sessions and raffled ... the Yorba Linda fitness center has to offer. ...
Breaking Medicine News(10 mins):Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 3Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 2Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 3Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 2Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 3Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 2Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 3Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 2Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 3
... Florida,s elected leaders,received a message from thousands ... Governor Charlie Crist and legislative leaders not to,eliminate ... the state,s most,vulnerable citizens., Driven by ambulance ... gurney,the petitions ask Governor Crist, Senate President Ken ...
... Corporation,(Nasdaq: HSKA ) announces the following Webcast:, What: Heska ... Stockholders on the Web, When: Tuesday, ... the Annual Meeting of Stockholders ... over the Internet -- Simply log on to the web at the ...
... a myocardial infarction is not higher for women than ... International (Dtsch Arztebl Int 2008; 105(15): 279-85), PD Dr. ... widely held view. , ( http://www.aerzteblatt-international.de/v4/archiv/pdf.asp?id=59860 ) , ... from AOK (a large general statutory health insurance company) ...
... -- Chindex International,Inc. (Nasdaq: CHDX ) a ... products in the People,s Republic of China, today,announced ... presentations at,the following investment conferences in New York ... All-China Conference being held,from May 19-20, 2008 at ...
... GHX honored 14 healthcare,provider and supplier organizations with its ... awards were,presented on Friday, April 18, 2008 during a ... Chain Summit, the largest healthcare,forum in the U.S. focused ... supply,chain., The theme of this year,s awards was ...
... men and often compresses the urethra resulting in voiding ... to measure the resistance of the urethra using sound: ... spectrum of the recorded sound depends on how much ... with voiding symptoms, such as a weak urinary stream ...
Cached Medicine News:Health News:Thousands Sign Petitions Urging Governor Crist and Legislative Leaders to Save Healthcare Coverage for 40,000 Floridians 2Health News:Thousands Sign Petitions Urging Governor Crist and Legislative Leaders to Save Healthcare Coverage for 40,000 Floridians 3Health News:Webcast Alert: Heska Corporation's Annual Meeting of Stockholders Webcast 2Health News:Chindex International, Inc. to Present at China Investment Conferences in New York City - May 20, 21, 22; Conferences Presented By Brean Murray, Carret & Co., Oppenhiemer & Co. and Citigroup 2Health News:Chindex International, Inc. to Present at China Investment Conferences in New York City - May 20, 21, 22; Conferences Presented By Brean Murray, Carret & Co., Oppenhiemer & Co. and Citigroup 3Health News:GHXcellence Awards Honor Healthcare Providers and Suppliers for Achievements in Supply Chain Performance 2Health News:GHXcellence Awards Honor Healthcare Providers and Suppliers for Achievements in Supply Chain Performance 3
CVC 123 is an assayed quality control material used for confirming the calibration and linearity of blood gas, electrolyte, and metabolite instrumentation....
... assayed quality control material used for monitoring the ... It is for specific use on Bayer analyzers ... 288, and 270) and the AVOX Systems CO-Oximeters ... used on the IRMA TRUpoint®. CC 527 is ...
... a quality control material that, once tonometered, ... blood gas, electrolyte, metabolite, and CO-Oximeter instrumentation. ... use of human blood in tonometry. QC ... for monitoring analyzer performance at varying points ...
... is an assayed quality control material ... blood gas, electrolyte, metabolite, and CO-Oximeter ... control makes it the ideal choice ... is available in three (3) levels ...
Medicine Products: